India Urology Market Size (2024 - 2029)

India Urology Market Analysis

The India Urology Market size is estimated at USD 355.13 million in 2024, and is expected to reach USD 599.81 million by 2029, growing at a CAGR of 9.03% during the forecast period (2024-2029).

The healthcare system had witnessed enormous challenges as a result of the COVID-19 pandemic. All outpatient treatments were postponed or restricted during the COVID-19 pandemic to reduce the risk of viral transmission as most chronic therapies were regarded as non-urgent. An article titled 'The Impact of the COVID-19 Pandemic on Urology Residents: a Narrative Review' published in the journal 'Current Urology Reports' in August 2021 indicated that the lack of personal protective equipment among the urology trainees in India had caused depression and anxiety among them, with many developing post-traumatic stress syndrome. Many of the residents in India also contracted the SARS-CoV-2 virus, which hindered the growth of the urology sector during the COVID-19 pandemic. As per the article, India reported a 90% reduction in the surgical volume and more than 80% of the urology residents estimated that their training was negatively impacted. Another article titled 'Uro-Oncology in Times of COVID-19: the Available Evidence and Recommendations in the Indian Scenario' published in the 'Indian Journal of Cancer in June 2020 studied the impact of delay in the management of various urological malignancies in the nation. Treatment for patients with renal cell carcinoma was deferred by three to six months, with only the essential immediate surgeries being performed. The reduction in the surgeries in the urology segment during the COVID-19 pandemic affected the growth of the urology market in the nation during the forecast period.

The rising number of initiatives by the Indian government on the use of medical devices adoption and promotion has been adding to the growth of the market over the forecast period. For instance, through the "Promotion of Medical Device Parks" scheme, the government seeks to improve India's infrastructure and create a strong manufacturing ecosystem for medical devices. The scheme will be in effect from FY 2020-21 to FY 2024-25. The initiative will provide funding for the construction of advanced infrastructure and facilities for standardized testing that will extend India's production value chain. This objective aims to lower production costs, improve accessibility, and enhance the affordability of medical equipment in the nation. Financial assistance from the Government valuing up to INR 400 crore will be provided to set up infrastructure facilities in selected four medical device parks.

Regular amendments to New Drugs, Medical Devices And Cosmetics Bill helps to improve the entry speed, price, and product quality regulation. In addition to this, a new bill of New Drugs, Medical Devices, And Cosmetics Bill was submitted by the Union Health Ministry in 2022. To regulate medical devices, a separate advisory board, Medical Devices Technical Advisory Board, is likely to establish along the lines of the existing drugs technical advisory board. Such initiatives will improve the regularization, quality, and thereby adoption of products in India. These initiatives by the Indian government are adding to the growth of the urology services market in the forecast period.

In addition, the technological advancements in the field of computer-assisted surgery, robotic surgery, and robotically-assisted surgery are expected to increase the accuracy and less loss of blood. For instance, in November 2021, Max Super Specialty Hospital, Patparganj, and Shalimar Bagh in India launched Da Vinci Xi Surgical Robot at the hospitals for performing robotic-assisted minimally invasive surgeries. This robotic system enables surgeons to perform complex surgeries with increased precision and flexibility under various disciplines like urology. Such advancements are expected to propel the market's growth over the forecast period.

However, the high cost of devices, the lack of adequate infrastructure and logistics, regulatory complications, low focus on research and development, counterfeiting, and imitations are some of the factors that are likely to restrict the growth of the market over the forecast period.

India Urology Industry Segmentation

As per the scope of this report, urology devices are medical devices used to diagnose and treat various disorders associated with the urinary tract systems. India Urology Market is segmented by Product Type (Stone Management Devices (Ureteroscopes, Catheters, Dilators, Retrieval devices, Stents, Access Sheath and Needles, Guidewires, Laser Accessories, and Laser Systems), Benign Prostate Hyperplasia (Holmium Laser System, Thulium Laser System, and Other Laser Types), Erectile Dysfunction (Vacuum Constriction Device and Penile Implants (Malleable/Non-Inflatable, Inflatable-2 Piece, and Inflatable-3 Piece)), and Urinary Incontinence Devices (Artificial Urinary Sphincters, Electrical Stimulation Devices, and Catheters)) and End User (Government Hospitals and Private Hospitals). The report offers values (in USD Million) and volume (in Thousand Units) for the above segments.